Vitamin E and atherosclerosis: Beyond prevention of LDL oxidation1,2

Journal of Nutrition

Volumn 131, Issue 2, 2001, Pages

  Meydani, M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

tocopherol; Atherosclerosis; Cardiovascular disease; Molecular mechanism

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; LIPID OXIDATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ARTERIOSCLEROSIS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; VITAMIN E;

EID: 0035152976     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study
2. Do vitamin E and fish oil protect against ischemic heart disease?
3. Acute phase response in exercise. II. Associations between vitamin E, cytokines, and muscle proteolysis
4. Oxidation of LDL by myeloperoxidase and reactive nitrogen species. Reaction pathways and antioxidant protection
5. Vitamin E supplementation attenuates myointimal proliferation of the abdominal aorta after balloon injury in diet-induced hypercholesterolemic rabbits
6. The effects of alpha tocopherol supplementation on monocyte function: Decreased lipid oxidation, interleukin 1β secretion, and monocyte adhesion to endothelium
7. Alphatocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism
8. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits
9. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C
10. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
11. Long-time treatment of intermittent claudication with vitamin E
12. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
13. Radio-labeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: Effect of vitamin E supplementation
14. GISSI-Prevenzione trial
15. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function
16. Dietary antioxidants and carotid artery wall thickness
17. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
18. Treatment of intermittent claudication with vitamin E
19. Vitamin E and vitamin C supplementation use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly
20. Vitamin E inhibits low density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro
21. 2 and aortic prostacyclin synthesis in rats
22. Lower ischemic heart disease incidence and mortaility among vitamin supplement users
23. Vitamin E deficiency in variant angina
24. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats
25. Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease
26. Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state
27. Risk of angina pectoris and plasma concentrations of vitamins A, C, E, and carotene
28. Vitamin E consumption and the risk of coronary heart disease in men
29. Low plasma beta-carotene, vitamin E and selenium levels associate with accelerated carotid atherosclerosis in hypercholesterolemic Eastern Finnish men
30. Serum fatty acids, apoliproteins, selenium and vitamin antioxidants and risk of death from coronary artery disease
31. Vitamin E consumption and the risk of coronary disease in women
32. Randomized, controlled trial of vitamin E in patients with coronary disease
33. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
34. Vitamin E supplementation and cardiovascular events in high-risk patients
35. The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
36. Alpha tocopherol in the treatment of intermittent claudication
37. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes